Previous Close | 0.0650 |
Open | 0.0650 |
Bid | 0.0600 x N/A |
Ask | 0.0650 x N/A |
Day's Range | 0.0650 - 0.0700 |
52 Week Range | 0.0150 - 0.5600 |
Volume | |
Avg. Volume | 70,425 |
Market Cap | 9.313M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, BC / ACCESSWIRE / May 1, 2024 /MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to announce that it has been presenting MindBio to various parties, institutional investment firms and brokerage ...
ASSESSING THE EFECTS OF MICRODOSING MB22001 IN MENSTRUATING PERSONS WITH AND WITHOUT PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHORIC DISORDER Multiple clinical trials in women’s health approved for take-home use of MB22001 MB22001 aims ...
MindBio scientist’s sleep research published in prestigious peer reviewed scientific journal MindBio’s proprietary treatment protocol using MB22001, results in longer sleep and better quality of sleep the day after microdosing VANCOUVER, ...